Q-Cells vs Sigenergy - solar panel manufacturer comparison
Q-Cells has the broader catalog (89 vs 0 models). Q-Cells leans bifacial (39% of lineup).
Both catalogues are read from the manufacturers' own datasheets. A brand is not scored against the market here, only against the other brand on this page.
The two companies
Qcells is a renowned global provider of complete energy solutions, specializing in solar cells and modules, energy storage solutions, downstream project business, and energy retail. The company has a strong heritage dating back to its foundation in Germany and has become a leader in technology innovations. As an...
- Founded
- 1999
- Headquarters
- Seoul, South Korea
- Annual capacity
- 11.2 GW/year
- Employees
- 2000+
- Listed
- NASDAQ: HQCL
- Tier 1 bankable
- Yes
Sigenergy is a Shanghai-based energy technology company specializing in all-in-one solar inverters, battery energy storage systems (BESS), and EV chargers for residential, commercial, and utility-scale applications. Founded in 2022 by Tony Xu, a former Huawei Smart PV executive, the company positions itself as the...
- Founded
- 2022
- Headquarters
- Shanghai, China
- Employees
- 500-1000
- Listed
- HKEX: 6656
Catalogue against catalogue
An average over a catalogue describes the range a manufacturer publishes, not the module you would buy. A brand with two flagship panels and eighty older ones averages worse than one that has retired its back catalogue.
What each of them builds
Q-Cells skews to higher efficiency: 2% of lineup is 23%+
Q-Cells offers more 600W+ panels (19% of lineup)
Dominant cell tech: <strong>PERC</strong> (43%)
The flagships
Written summary
Q-Cells traces its origins to Q-Cells AG, a German solar pioneer founded in 1999 in Bitterfeld that became one of the world's leading cell manufacturers before being acquired by South Korea's Hanwha Group in 2012. Now operating as Hanwha Q CELLS, it holds BloombergNEF Tier 1 bankability status and runs the largest silicon solar module manufacturing capacity in the United States, with roughly 8.4 GW of annual output split between two plants in Dalton and Cartersville, Georgia. Sigenergy (Sigenergy Technology Co., Ltd.) is a far newer entrant, founded in 2022 in Shanghai by Tony Xu, a former Huawei Smart PV president, and listed on the Hong Kong Stock Exchange. On institutional depth and longevity, Q-Cells has a clear and substantial advantage.
The two companies occupy different positions in the solar supply chain and are not direct substitutes. Q-Cells is a solar module manufacturer; its current flagship Q.TRON series is built on proprietary n-type TOPCon technology - branded Q.ANTUM NEO - and reaches module efficiencies up to roughly 22.5%, targeting residential and commercial rooftop installations with a 25-year product warranty. Sigenergy does not manufacture solar panels at all. It produces integrated energy systems: its SigenStor platform combines a hybrid solar inverter, modular battery storage scalable from 6 kWh to 54 kWh, and a built-in EV DC charger in one stackable unit. Frost and Sullivan ranked Sigenergy first globally in stackable all-in-one distributed energy storage shipments for 2024, and in early 2025 it briefly led Australia's battery market by blended installed capacity - though a voluntary safety recall of single-phase inverters in Australia in late 2025 is a caution worth noting for a still-young brand.
For a buyer choosing solar panels, Q-Cells is the directly relevant option: a Tier 1 bankable manufacturer with a multi-decade track record, significant domestic US production, and a broadly respected warranty program. Sigenergy becomes the relevant choice - or a complementary one - when the focus is on storage and inverter hardware. The two brands are better understood as potential partners in the same system than as rivals in the same category.
Generated by Claude Sonnet · 2026-06-07
Other brand comparisons
Shop prices: See 25 Q-Cells offers
Comparisons are computed from manufacturer datasheets held in the ComparePV database and may not reflect a brand's complete current lineup. Nothing on this page is paid placement.